Inactive Instrument
Isodiol International Inc Stock Canadian Securities Exchange
Stocks
CA46500L1013
Pharmaceuticals
OTC Markets Traded| Market Cap | 3.91M 2.78M 2.41M 2.25M 2.07M 265M 3.95M 26.54M 10.38M 132M 10.44M 10.21M 438M | P/E 2018 |
-4.94x | P/E 2019 | -0.37x |
|---|---|---|---|---|---|
| Enterprise Value | 9.13M 6.49M 5.64M 5.26M 4.83M 618M 9.23M 61.98M 24.23M 309M 24.38M 23.85M 1.02B | EV / Sales 2018 |
12.6x | EV / Sales 2019 | 2.48x |
| Free-Float |
100% | Yield 2018 * |
-
| Yield 2019 | - |
| 1 day | -3.58% |
| Manager | Title | Age | Since |
|---|---|---|---|
Marcos Agramont
CEO | Chief Executive Officer | - | 2017-05-23 |
Andrew Alvis
DFI | Director of Finance/CFO | - | - |
| Corporate Officer/Principal | - | 2018-08-29 |
| Director | Title | Age | Since |
|---|---|---|---|
Marcos Agramont
BRD | Director/Board Member | - | 2017-05-23 |
| Director/Board Member | - | 2018-08-29 | |
| Director/Board Member | - | 2018-11-20 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -3.58% | +881.08% | - | - | 128 | |
| -1.13% | +0.52% | -7.86% | -4.52% | 13.81B | |
| -1.30% | +1.10% | -30.58% | -53.14% | 5.3B | |
| -1.44% | +5.00% | +5.96% | +8.76% | 5.23B | |
| +0.42% | +1.14% | +3.01% | -31.83% | 4.13B | |
| -0.11% | +3.79% | -8.23% | -2.80% | 3.75B | |
| -1.75% | -0.26% | -2.80% | +5.31% | 3.66B | |
| -0.31% | +0.76% | -4.17% | +13.86% | 3.52B | |
| -1.00% | +1.15% | -13.90% | -22.43% | 2.49B | |
| -1.17% | +1.56% | -2.60% | +52.13% | 1.92B | |
| Average | -1.14% | -0.28% | -6.80% | -3.85% | 4.87B | |
| Weighted average by Cap. | -0.93% | -0.23% | -7.36% | -7.48% |
| 2018 | 2019 | |
|---|---|---|
| Net sales | 19.14M 13.61M 11.81M 11.01M 10.12M 1.29B 19.35M 130M 50.77M 647M 51.09M 49.97M 2.14B | 22.25M 15.82M 13.73M 12.81M 11.76M 1.5B 22.49M 151M 59.02M 752M 59.4M 58.1M 2.49B |
| Net income | -36.02M -25.61M -22.24M -20.73M -19.05M -2.44B -36.42M -244M -95.55M -1.22B -96.17M -94.06M -4.03B | -126M -89.52M -77.73M -72.47M -66.58M -8.52B -127M -854M -334M -4.26B -336M -329M -14.1B |
| Net Debt | -15.55M -11.06M -9.6M -8.95M -8.22M -1.05B -15.72M -106M -41.25M -526M -41.52M -40.61M -1.74B | 5.22M 3.71M 3.22M 3.01M 2.76M 353M 5.28M 35.44M 13.85M 177M 13.94M 13.64M 585M |
Employees
-
Sector
Pharmaceuticals
